Literature DB >> 20584810

Measuring circulating miRNAs: the new "PSA" for Breast Cancer?

Jeffrey S Ross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20584810      PMCID： PMC3228009          DOI： 10.1634/theoncologist.2010-0176

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  4 in total

1.  Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

Authors:  Helen M Heneghan; Nicola Miller; Ronan Kelly; John Newell; Michael J Kerin
Journal:  Oncologist       Date:  2010-06-24

Review 2.  miRNA: the new gene silencer.

Authors:  Jeffrey S Ross; J Andrew Carlson; Graham Brock
Journal:  Am J Clin Pathol       Date:  2007-11       Impact factor: 2.493

3.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

Review 4.  MicroRNAs and the hallmarks of cancer.

Authors:  T Dalmay; D R Edwards
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867
  4 in total
  1 in total

1.  Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.

Authors:  Jie Shen; Qiang Hu; Michael Schrauder; Li Yan; Dan Wang; Leonardo Medico; Yuqing Guo; Song Yao; Qianqian Zhu; Biao Liu; Maochun Qin; Matthias W Beckmann; Peter A Fasching; Reiner Strick; Candace S Johnson; Christine B Ambrosone; Hua Zhao; Song Liu
Journal:  Oncotarget       Date:  2014-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.